As a result of the the pandemic we face, life-and-death choices will be made and often, artificial intelligence and machine learning can be used to make objective and informed recommendations. This editorial explores the challenges faced by healthcare systems, and how AI and machine learning can improve decision-making.
Browsing: Research > Clinical
A vaccine against MERS has shown promise in mouse models, potentially aiding the development of a vaccine against COVID-19.
As the coronavirus surges across the globe, diagnostic testing comes into its own, as researchers unite to confront, delay and stop its spread. In the absence of either proven effective therapy or a vaccine, diagnostic testing becomes a valuable tool.
Researchers from the University of Pittsburgh (PA, USA) have revealed the results from preclinical research testing their COVID-19 vaccine candidate in mice.
It’s a commonly known fact that the current global pandemic caused by the coronavirus originated in Wuhan, China. Over the first 50 days, a series of control measures were implemented to impede the spread, but were these measures effective?
There has been much contention regarding how the deadly COVID-19 pandemic originated. The first reported case of the disease was in Wuhan (Hubei province, China). The virus – SARS-CoV-2 – is believed to have been passed from animals to humans, but new data reveals pangolins could be linked to COVID-19 transmission.
In this interview we speak to Deepali Kumar about vaccination in the immunocompromised population, including guideline updates, understanding immunology and the future of this field.
Moderna has announced that the first participants have been dosed in a Phase I study of their mRNA candidate vaccine against SARS-CoV-2, the virus that causes COVID-19.
The first clinical trial assessing two triple artemisinin-based combination therapies (TACTs) for treating malaria has suggested these are effective and present no safety concerns.